首页
订购/客服:400-666-5481

CO-1686 (hydrobromide)

    
≥98%

CO-1686 (hydrobromide)

源叶(MedMol)
S83369 一键复制产品信息
1446700-26-0
C27H29BrF3N7O3
636.4634
Rociletinib hydrobromide
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S83369-5mg
≥98%

¥490.00

货期:3-5天 - - - -
S83369-10mg
≥98%

¥790.00

货期:3-5天 - - - -
S83369-50mg
≥98%

¥1490.00

货期:3-5天 - - - -
S83369-100mg
≥98%

¥2490.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Rociletinib hydrobromide (CO-1686 hydrobromide) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.
靶点: EGFRL858R/T790M:21.5 nM (Ki);EGFRT790M:303.3 nM (Ki);Others
体外研究: Rociletinib (0.1 μM) inhibits EGFR potently and irreversibly, and inhibits more than 50% of 23 targets. Rociletinib potently and selectively inhibits growth of NSCLC cells expressing mutant EGFR and induces apoptosis. Rociletinib resistant NSCLC cell lines are sensitive to AKT inhibition
体内研究: Rociletinib (100 mg/kg/day, p.o.) demonstrates anti-tumor activity in NSCLC EGFR mutant xenograft models. Rociletinib (50 mg/kg bid, p.o.) demonstrates anti-tumor activity in human EGFR-L858R and EGFR-L858R-T790M expressing transgenic mice
参考文献: 1. Walter AO, et al. Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov. 2013 Sep 25.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.571 ml 7.856 ml 15.712 ml
5 mM 0.314 ml 1.571 ml 3.142 ml
10 mM 0.157 ml 0.786 ml 1.571 ml
50 mM 0.031 ml 0.157 ml 0.314 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×